Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
NeuroOne Medical Technologies CEO David Rosa disposed of 4,697 shares of common stock on September 30, 2024, to cover tax obligations related to vested shares.
Summary
- On September 30, 2024, David A. Rosa, CEO and President of NeuroOne Medical Technologies Corp, disposed of 4,697 shares of common stock.
- The transaction was executed at a price of $0.99 per share.
- This disposal was to cover tax obligations.
- Following the transaction, Rosa directly owns 1,146,486 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a transaction to cover tax obligations, which is a routine event.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade their company's stock. It provides transparency to the market about insider activity.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant as it is for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of transaction: David Rosa disposed of shares. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.